Literature DB >> 1977060

Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis.

Y Gruel, M Lang, L Darnige, G Pacouret, X Dreyfus, J Leroy, B Charbonnier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1977060     DOI： 10.1016/0140-6736(90)92558-y

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Perspectives on the long term management of heparin-induced thrombocytopenia.

Authors:  D Brieger
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

Review 2.  Heparin-induced thrombocytopenia: present and future.

Authors:  Adam Cuker
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

3.  Drug-Induced Thrombocytopenia: Is it a Serious Concern for Glycoprotein IIb/IIIa Receptor Inhibitors?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-07       Impact factor: 2.300

4.  Catastrophic heparin-induced thrombocytopenia/thrombosis syndrome related to the use of a Port-A-Cath in a breast cancer patient receiving chemotherapy.

Authors:  Ming-Shen Dai; An-Tie Hsieh; Tsu-Yi Chao
Journal:  Support Care Cancer       Date:  2004-04-28       Impact factor: 3.603

Review 5.  Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance.

Authors:  W N Patton; S B Duffull
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

6.  Critical role for mouse marginal zone B cells in PF4/heparin antibody production.

Authors:  Yongwei Zheng; Mei Yu; Andrew Podd; Liudi Yuan; Debra K Newman; Renren Wen; Gowthami Arepally; Demin Wang
Journal:  Blood       Date:  2013-03-04       Impact factor: 22.113
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.